12:00 AM
 | 
Jun 26, 2000
 |  BC Week In Review  |  Company News  |  Deals

North American Vaccine, Baxter deal

NVX shareholders approved the acquisition of NVX by BAX, which was amended in April...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >